Latest Diabetology Ltd Stories

2014-02-11 08:32:23

LA CHAUX-DE-FONDS, Switzerland, February 11, 2014 /PRNewswire/ -- Kareus Therapeutics SA ("Kareus") announced today that US FDA has approved its Investigational New Drug (IND) KU-5039 to initiate Phase I clinical trial. KU 5039 is being developed for the treatment of insulin resistance and diabetes. KU-5039 is an orally active, New Chemical Entity (NCE), discovered and developed by Kareus. KU-5039 is a potent and selective activator of AMP-kinase (AMPK), a key...

2008-11-06 11:17:54

Sweden-based biopharmaceutical company Diamyd Medical has reported that six European countries have approved the initiation of a Phase III study with the Diamyd diabetes vaccine for type 1 diabetes. The application processes to the national regulatory agencies and ethics committees have proceeded according to plan, and the company has now received agency approvals for a European Phase III study of children and adolescents with type 1 diabetes in the Netherlands, UK, Finland, Slovenia, Spain...

2008-03-25 12:00:19

WORCESTER, Mass., March 25, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has received a Purchase Order for 210,000 canisters of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, from Shreya Life Sciences Pvt. Ltd. (www.shreya.co.in), the Company's distributor in India. This is the first Indian commercial order for the...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.